- Home
- BSY vs ARWR Comparison
BSY vs ARWR Comparison
Compare BSY & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BSY | ARWR |
|---|---|---|
| Founded | 1984 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.8B | 10.1B |
| IPO Year | 2002 | 2009 |
Fundamental Metrics
Financial Performance| Metric | BSY | ARWR |
|---|---|---|
| Price | $34.03 | $63.49 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 11 |
| Target Price | $52.33 | ★ $77.55 |
| AVG Volume (30 Days) | ★ 3.0M | 2.6M |
| Earning Date | 01-01-0001 | 05-08-2026 |
| Dividend Yield | ★ 0.82% | N/A |
| EPS Growth | N/A | ★ 99.80 |
| EPS | ★ 0.67 | 0.22 |
| Revenue | ★ $734,849,000.00 | $16,142,321.00 |
| Revenue This Year | $11.37 | N/A |
| Revenue Next Year | $10.42 | N/A |
| P/E Ratio | ★ $51.01 | $289.86 |
| Revenue Growth | ★ 6.24 | N/A |
| 52 Week Low | $30.97 | $10.66 |
| 52 Week High | $59.25 | $76.76 |
Technical Indicators
Market Signals| Indicator | BSY | ARWR |
|---|---|---|
| Relative Strength Index (RSI) | 40.96 | 45.95 |
| Support Level | $32.84 | $60.89 |
| Resistance Level | $35.04 | $65.59 |
| Average True Range (ATR) | 1.35 | 3.91 |
| MACD | 0.18 | -0.47 |
| Stochastic Oscillator | 67.88 | 20.48 |
Price Performance
Historical ComparisonAbout BSY Bentley Systems Incorporated Class B
Bentley Systems is a software vendor that caters to civil engineers, constructors, and geospatial professionals by enabling design, simulation, and data management of infrastructure assets such as roads and bridges. While Bentley is smaller than many other design software companies, it is a market leader across a handful of specialty areas, including public works, electricity grids, and transit.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.